Rezultati - Mark Messing

  • Mostrando 1 - 1 resultados de 1
Refinar Resultados
Seznam   Mreža  
  1. 1

    354 Lenvatinib and pembrolizumab in advanced endometrial carcinoma (EC): long-term efficacy and safety update from a phase 1b/2 study od Emmett Schmidt, Matthew Taylor, Allen Cohn, Corina Dutcus, Marcia Brose, Robert Orlowski, Jie Huang, Carol Aghajanian, Margarita Romeo, Raquel Bratos, Mark Messing, Lea Dutta

    Izdano 2021-11-01
    Artigo
    Dodaj v priljubljene
    Shranjeno v:

Iskalna orodja: